IP Verse

Metabolically Optimized Cell Culture

Patent No. EP3351620 (titled "Metabolically Optimized Cell Culture") was filed by Regeneron Pharmaceuticals on Oct 10, 2014. The application was issued on Sep 2, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BREUERJun 2, 2021BREUER FRIEDRICH HAHNER PATENTANWALTE PARTG MBB
NEUEFEINDJun 2, 2021MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3351620

REGENERON PHARMACEUTICALS
Application Number
EP18161278A
Filing Date
Oct 10, 2014
Status
Revoked
Apr 22, 2022
Publication Date
Sep 2, 2020
External Links
Slate, Register , Google Patents